Propanc Biopharma Shares Advance Following Nasdaq Debut

MT Newswires Live
Aug 18, 2025

Propanc Biopharma (PPCB) shares jumped more than 146% in recent Monday trading following their debut on Nasdaq on Friday.

Intraday trading volume was more than 48 million shares.

The company said last week it expects to close on Monday its initial public offering of 1 million shares.

Price: 7.08, Change: +4.21, Percent Change: +146.52

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10